Analysts Set Exactech, Inc. (EXAC) Price Target at $49.00

Exactech, Inc. (NASDAQ:EXAC) has been given a consensus recommendation of “Hold” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $49.00.

Separately, BidaskClub lowered Exactech from a “sell” rating to a “strong sell” rating in a research note on Tuesday, January 30th.

Several large investors have recently added to or reduced their stakes in EXAC. Water Island Capital LLC bought a new stake in shares of Exactech during the 4th quarter valued at $26,772,000. Gabelli Funds LLC raised its stake in shares of Exactech by 138.7% during the 4th quarter. Gabelli Funds LLC now owns 701,748 shares of the medical equipment provider’s stock valued at $34,701,000 after purchasing an additional 407,724 shares during the period. Kennedy Capital Management Inc. bought a new stake in shares of Exactech during the 4th quarter valued at $17,938,000. Pentwater Capital Management LP bought a new stake in shares of Exactech during the 4th quarter valued at $12,363,000. Finally, Gamco Investors INC. ET AL raised its stake in shares of Exactech by 24.8% during the 4th quarter. Gamco Investors INC. ET AL now owns 764,508 shares of the medical equipment provider’s stock valued at $37,805,000 after purchasing an additional 151,991 shares during the period. Institutional investors own 61.22% of the company’s stock.

NASDAQ:EXAC opened at $49.25 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.08 and a quick ratio of 2.09. Exactech has a 52-week low of $23.75 and a 52-week high of $50.95.

Exactech Company Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply